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Higher urinary IgM excretion in type 2 diabetic nephropathy renal failure in Europe and U.S. [1]. However, several
compared to type 1 diabetic nephropathy. clinical findings indicate that the pathophysiological
Background. Proteinuria, due to impairment of the charge- mechanisms of proteinuria might differ between DN inand/or size selectivity of the glomerular capillary wall (GCW)
type 1 diabetes mellitus (type 1 DN) and type 2 diabetesis the earliest clinical evidence of diabetic nephropathy (DN).
mellitus (type 2 DN) [2–4]. For example, angiotensin-To study the pathophysiological differences between patients
with DN in type 1 diabetes mellitus (type 1 DN) and type 2 dia- converting enzyme (ACE) inhibitors decrease protein-
betes mellitus (type 2 DN), we compared the patterns of urinary uria in patients with type 1 DN but have no influence
proteins of different size and charge in the two entities of on proteinuria in type 2 DN [5].diabetic kidney disease.
Transport of proteins across the glomerular capillaryMethods. Urine concentrations of albumin, IgG2, IgG4 and
wall is determined by the size- and charge-selectivity ofIgM were assessed in 22 (15 males and 7 females) patients with
type 1 DN, and in 20 (18 males and 2 females) patients with the filtration barrier and by the size, shape and charge
type 2 DN. Comparisons with one control group of 13 (12 of the transported macromolecules [6, 7]. The widely
males and one female) patients with nephrosclerosis due to
used description of this transport is based on hypotheti-systemic hypertension and a second control group of 16 (14
cal, water-filled, cylindrical pores perforating the glomer-males and 2 females) healthy controls were made.
Results. The urine excretion of IgG2 and IgM and the ratio ular filter [8]. In a “two-pore with a shunt” model the
of IgG2 to IgG4 (IgG2/IgG4), were significantly higher in type 2 pores consist of two populations [9]. The vast majority of
DN compared to type 1 DN (P  0.01). Patients with type 2 the pores are “small pores” of radius 2.9–3.1 nm vis-a`-vis
DN and patients with nephrosclerosis had significantly higher
negatively charged rigid spherical proteins. The remain-urine excretion of IgG and IgM compared to the age-matched
ing pore population consists of a small number of “largehealthy subjects (P  0.001). The IgG2/IgG4 ratio was higher
in type 2 DN compared to nephrosclerosis and healthy controls pores” of radius 8 to 9 nm [10]. The small pores are es-
(P  0.01). sentially impermeable to proteins the size of albumin
Conclusion. The increased urine excretion of IgG and IgM (mol radius 3.6 nm) or larger. Such macromolecules arethat accompanies albuminuria in type 2 DN suggests that the
normally transported by convection across the large poresdominant pathophysiological mechanism of proteinuria in type 2
[11]. In addition to the two populations of pores, the in-DN might be an alteration of the size selective properties of the
glomerular capillary wall, including the occurrence of non-dis- tact glomerular capillary wall exhibits very sporadic physi-
criminatory “shunt pathways.” The charge selective properties ological “membrane defects” or “shunts” large enough to
of the glomerular capillary wall seem to be intact in type 2 DN, allow transport of very large proteins and red blood cellsas indicated by the high IgG2/IgG4 ratio. The mechanisms of
[10, 11].proteinuria in type 1 DN seem to be merely a consequence of
The loss of negative charges of the glomerular capil-an impaired charge selectivity of the glomerular capillary wall.
lary wall causes the “effective” small pore radius vis-a`-vis
negatively charged macromolecules to increase to4.5 nm,
Diabetic nephropathy (DN) is a severe complication which allows passage of albumin. Larger proteins, such
of both type 1 and type 2 diabetes mellitus. The disease as IgG (mol radius 5.5 nm) or IgM (mol radius 12 nm)
has become the most common single cause of end-stage are still unable to pass across this pathway. IgG passes
the glomerular capillary walls through the large pores
while IgM can permeate the glomerular capillary wallKey words: albuminuria, IgG, IgM, macromolecular transport, protein-
uria, charge selectivity, glomerular capillary wall, diabetes mellitus. solely through the shunts [10, 12]. Thus, increased trans-
port of IgG indicates increased density of large pores andReceived for publication April 27, 2001
increased concentration of urine IgM indicates increasedand in revised form August 12, 2001
Accepted for publication August 17, 2001 density of shunts in the glomerular capillary wall [12].
Our previous findings show that the large pore radius 2002 by the International Society of Nephrology
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is in the range of 9 nm [10, 13]. Thus, the protein traffic and the median HbA1c level was 8.6% (6.8 to 13). None
of the patients in the group had a history of hypertensionthrough the large pores is, in parallel with the small
before the onset of diabetes. Fifty-eight percent of thepore pathway, influenced by the charge properties of the
patients were on ACE inhibitors during the time of thetransported macromolecules and the glomerular capil-
investigation.lary wall [14]. Since IgG2 is a neutral and IgG4 a negative
Because of the usually high incidence of essential hy-charged molecule, high value of urine IgG2 to IgG4 ratio
pertension in patients with type 2 diabetes mellitus, an(IgG2/IgG4 ratio) reflects preserved charge selectivity of
age matched control group consisting of 13 patients (12the glomerular capillary wall. In parallel, a low IgG2/
males and one female) with biopsy verified nephrosclero-IgG4 ratio suggests a loss of the charge selectivity of the
sis secondary to hypertension, was selected. The patientsglomerular capillary wall.
participated in a large investigative program of all formsWith these considerations in mind we investigated the
of glomerular diseases conducted at the Department oftransport of macromolecules across the glomerular filter
Nephrology at Lund University Hospital between 1993in type 1 DN and type 2 DN. We used urine IgG as
and 1997. The renal biopsy findings in this group showed,marker of the large pore pathway and urine IgM as
on average, 45% of glomeruli affected with global glo-marker of the shunt transport. Urine albumin and the
merulosclerosis and moderate-to-severe interstitial fibro-IgG2/IgG4 ratio were used to study the charge influence
sis in 69% of the biopsies. The estimated duration of theon the transport through the small pores and the large
medical treatment for high blood pressure was 15 (2 topores, respectively.
37) years.
An additional control group consisting of 16 (14 males
METHODS and 2 females) apparently healthy individuals was used
in the study. The inclusion criteria for the healthy con-Twenty-five patients (22 males and 3 females) with
trols, in addition to laboratory test results within the ref-type 2 DN, who participated in a renal biopsy study con-
erence limits used at our laboratory [14], were no historyducted at Lund University Hospital between February
of ongoing diseases and no current medication. The blood1997 and December 1999, were invited to take part in
pressure had to be less than 165 mm Hg systolic andthe current investigation. Twenty patients (18 males and
90 mm Hg diastolic pressures. All the subjects gave in-2 females) with persistent macroalbuminuria (albumin
formed consent. Table 1 shows the patient demographics.creatinine index 20 mg/mmol) entered the study. The
Type 2 DN patients were older than type 1 DN patientspatients had typical DN findings on the light microscopy
(P 0.01; Table 1). There was no difference in regard toexamination of the renal biopsy, such as nodular and
the sex distribution, age, serum creatinine, and creatininediffuse glomerulosclerosis and diffuse arteriolar hyalino-
clearance (CCr) between type 2 DN, nephrosclerosis andsis. Global glomerulosclerosis was found in 14 patients,
the healthy control subjects. Mean arterial blood pres-affecting on average 24% (8 to 55%) of the glomeruli.
sure was significantly higher in type 2 DN and nephro-Moderate-to-severe interstitial fibrosis was seen in five pa-
sclerosis compared to healthy subjects (Table 1).tients, and four patients had a normal interstitium. The
Serum and urine creatinine was determined enzymati-known duration of diabetes mellitus was 17 (6 to 35%)
cally using a Kodak Ektachem 700 XR-C system (East-years and the median HbA1c level was 8.6% (5.5 to man Kodak, Rochester, NY, USA). Morning urine sam-10.7%). The diagnosis of type 2 diabetes mellitus was
ples from patients with no signs of urinary tract infection
established if the patient did not need insulin for at least and menstruation, and with negative urine strip for hemo-
two years after the diagnosis of diabetes. All patients globin were used. Urine samples were stored in 3.5-mL
except one were treated with insulin during the time of polypropene plastic tubes and kept at20C. Urine albu-
the study. The daily average insulin dose was 62 (range min, urine 1-microglobulin and serum albumin, serum
16 to 138) IU. Fifty-six percent of the patients had a IgG and serum IgM were determined by immunoturbidi-
history of medically treated hypertension before or at metry, using a Cobas Mira S system (Roche Inc.) and
the diagnosis of the diabetic disease and 83% of the monospecific rabbit antisera obtained from Dako (Co-
patients were receiving ACE inhibitors during the study. penhagen, Denmark) [14–16]. Agarose gel electrophore-
Twenty-two patients with type 1 DN (15 males and 7 sis of plasma was done on all blood samples to exclude
females) were recruited to the study among the patients the presence of the M component. Urine IgG2, IgG4, and
at the outpatients’ diabetic department at Lund Univer- IgM were measured by the ELISA technique presented
sity Hospital. The inclusion criteria were macroalbumin- earlier [13, 17], and the lower detection limits for IgG2
uria (albumin creatinine index 20 mg/mmol in at least and IgM was 0.05 mg/L, and for IgG4 was 0.1 mg/L.
two out of three consecutive urine samples) and serum
Calculationscreatinine concentration below 250 mol/L. The mean
duration of the diabetic disease was in this group 25 (15 Creatinine clearance (CCr) was calculated using the
Cockcroft and Gault formula [18], where:to 41) years. The daily insulin dose was 41 (24 to 88) IU,
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Table 1. Characteristics of patients with diabetic nephropathy of type 1 (1 DN) and type 2 (2 DN) diabetes, healthy control
subjects and patients with nephrosclerosis
Healthy Nephrosclerosis 2 DN 1 DN P value
Number 16 13 20 23 NS
Sex male/female 14/2 12/1 18/2 15/8 NS
Age years 60 (3.3) 57 (3.5) 59 (2.2) 38 (1.6) 0.001
MAP mm Hg 93.6 (2.2) 117.8 (4.6)a 105.6 (2)a 102 (2) NS
Creatinine lmol/L 85 (2.8) 143 (14.4)a 113 (11.3) 130 (11.4) NS
Creatinine clearance mL/min 89.7 (8.7) 57.8 (6.6) 75.8 (8) 76.5 (6.7) NS
P value represents the difference between type 1 and type 2 diabetic patients. Significance level was at P  0.01 (two-tailed).
a Significant difference in comparison to healthy control subjects
Table 2. Mean value of fractional clearance and urinary excretion of albumin, IgG2, IgG4, IgM and 1-microglobulin and the
IgG2/IgG4 ratio, in type 1 (1 DN) and type 2 (2 DN) diabetes with nephropathy, nephrosclerosis patients and healthy subjects
Healthy Nephrosclerosis 2 DN 1 DN P value
Fractional protein clearance (	106) of
Albumin 1.8 (0.36) 499 (172)a 379 (92)a 327 (79) NS
IgG2 2.5 (1.2) 100 (32)a 370 (77)a 185 (93) 0.001
IgG4 3.1 (2.1) 104 (41)a 159 (52)a 211 (122) NS
IgM 0.15 (0.07) 4.5 (2.9)a 2.6 (0.65)a 0.4 (0.09) 0.004
Urine protein creatinine index (mg/mmol) of
Albumin 0.81 (0.15) 132 (27)a 106 (20)a 82 (12.7) NS
IgG2 0.19 (0.14) 6.9 (2.6)a 36.3 (7.5)a 10.2 (4.45) 0.001
IgG4 0.35 (0.25) 9.3 (4.5)a 13.6 (4.1)a 13.5 (6.3) NS
IgM 1.8 (0.74)	103 24.1 (7.6)a	103 21.4 (5)a	103 4 (0.95)	103 0.011
1-microglobulin 0.5 (0.07) 3.2 (0.86)a 2.1 (0.43)a 2.8 (0.87) NS
IgG2/IgG4 ratio 2.3 (0.71) 1.12 (0.26) 15.95 (7.1)a 3.74 (2.6) 0.001
P value is difference between type 1 DN and types 2 DN. Significance level was at P  0.01 (two tailed).
a Significant difference in comparison to healthy control subjects
CCr 
 [88 	 (145  age)/serum creatinine (mol/L)]  3 Mann-Whitney test. Correlations were tested using the
Spearman correlation coefficient. For urinary concentra-
and where it is 15% lower for women. (Eq. 1) tions of IgM below the detection limits, 0.01 mg/L was
used. The statistical package for social science (versionFractional clearance of proteins was calculated ac-
10; SPSS, Chicago, IL, USA) was used. P  0.05 wascording to the formula:
selected as the level of significance.
Urine protein (g/L) 	 serum creatinine (mol/L)
Serum protein (g/L) 	 urinary creatinine (mol/L)
(Eq. 2)
RESULTS
The IgG2/IgG4 ratio was calculated as: Patients with type 1 DN and type 2 DN did not differ
in regard to the degree of albuminuria, serum creatinine,Urine IgG2 concentration (mg/L)
Urine IgG4 concentration (mg/L)
(Eq. 3) CCr, urine protein -1 microglobulin concentrations, lev-
els of HbA1c, or the mean arterial blood pressure (Ta-
The albumin creatinine index (mg/mmol) was de- bles 1 and 2).
fined as ratio of urine albumin (mg/L) to urine creati- The urine IgG2/IgG4 ratio was higher (P  0.01) in
nine (mmol/L). The IgG creatinine index (mg/mmol) was type 2 DN compared to type 1 DN patients (Fig. 1).
defined as ratio of urine IgG (mg/L) to urine creatinine Type 2 DN patients had increased urine excretion of
(mmol/L), while the IgM creatinine index (mg/mmol) IgM and IgG2 compared to type 1 DN patients (P 
was defined as ratio of urine IgM (mg/L) to urine creati- 0.01; Table 2). Urine concentration of IgM was below
nine (mmol/L). The 1-microglobulin creatinine index the detection limit in 19 out of 22 type 1 DN patients
(mg/mmol) was defined as ratio of urinary 1-microglob- (86%) and only in 7 out of 20 (35%) type 2 DN patients
ulin (mg/L) to urinary creatinine (mmol/L). (Fig. 2). Urinary excretion of IgG2 correlated to urinary
IgG4 in type 1 DN (r 
 0.82, P  0.01) but not in type
Statistical methods 2 DN (r 
 0.38, NS). Increased urine excretion of albu-
The data in the Tables are expressed as medians fol- min in type 2 and type 1 DN correlated to decreased CCr
lowed by ranges. Statistical comparisons between the (r 
 0.55, and 0.56, respectively, P  0.05) but not to
urinary excretion of IgG or IgM.patient groups were performed with the non-parametric
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Fig. 3. Urinary IgG2 excretion in diabetic nephropathy due to type 1Fig. 1. Urine IgG2 to IgG4 ratio in diabetic nephropathy due to type
and type 2 diabetes and in control groups.1 and type 2 diabetes and in control groups.
tients (P 0.01; Table 2 and Fig. 3). The increased urine
1-microglobulin excretion in type 2 DN and nephroscle-
rosis did not correlate with increased urine IgG and IgM
excretion (r
 0.12 and 0.25, respectively, NS). The IgG2/
IgG4 ratio was higher in type 2 DN compared to the
nephrosclerosis (P  0.001) as well as healthy subjects
(P  0.01; Fig.1).
DISCUSSION
Proteinuria is widely regarded as a hallmark of ne-
phropathy and is the most common clinical manifestation
of DN in both type 1 and type 2 diabetes. Many experi-
mental studies in diabetic disease have demonstrated
that decreased heparan sulfate content causes a reduc-
tion of the fixed negative charges of the glomerular bar-
rier resulting in increased urine albumin excretion. Since
IgG is transported mainly through the large pores of the
glomerular capillary wall, the finding of increased urine
concentration of IgG in type 2 DN is suggestive of in-Fig. 2. Urinary IgM excretion in diabetic nephropathy due to type 1
and type 2 diabetes and in control groups. creased number of large pores. This increase might be
the major pathophysiological mechanism of albuminuria
in type 2 DN. This assumption is further supported by
the preserved charge-selectivity of the glomerular barrierType 2 DN patients had a significantly higher degree
as indicated by the high IgG2/IgG4 ratio in type 2 DN.of albuminuria and many-fold higher urinary IgG and
With the intact charge-selectivity of the glomerular capil-urinary IgM concentrations than the healthy control sub-
lary wall, the small pore pathway is virtually imperme-jects (P  0.001; Table 2). There were no differences in
able for albumin and the main transport of the proteinthe urinary excretion of albumin, IgM or 1-microglobu-
occurs through the large pore pathway.lin between patients with type 2 DN and nephrosclerosis.
The appearance of IgM in the final urine found in type 2However, type 2 DN patients had an increased urinary
excretion of IgG2 compared to the nephrosclerosis pa- DN reflects a markedly increased population of the highly
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nonselective pathways, that is, “shunts.” This is an addi- of the GCW to be 9 nm, the expected clearance of anionic
IgG should increase fourfold in comparison to the clear-tional support for the hypothesis of the size selective
dysfunction of the glomerular barrier in type 2 DN. We ance of the neutral IgG when the charge selectivity of
the capillary wall is completely lost. The decrease in thesuggest that an increased size in pore area and an in-
creased number of shunts occur in parallel in type 2 DN. IgG2/IgG4 ratio obtained in this study in patients with
type 1 DN compared to type 2 DN in fact correspondsThe significantly smaller amount of the urinary excre-
tion of IgG2 and IgM in patients with type 1 DN com- to what could be expected from the above calculations.
The mean IgG2/IgG4 ratio was 3.7  2.5 in type 1 DNpared to that in type 2 DN, despite a similar degree of
albuminuria and kidney function impairment, suggests and 16  7.1 in type 2 DN patients. In at least 80% of
patients with type 2 diabetes mellitus, hypertension orthat the size selective properties of the glomerular capil-
lary wall are relatively intact in type 1 DN. However, the abnormal circadian blood pressure profile is found at
impairment of the charge-selectivity of the glomerular the diagnosis of the diabetic disease [23]. In hypertensive
capillary wall in type 1 DN, indicated by the low IgG2/ patients, blood pressure correlates to the decrease in
IgG4 ratio, causes an increase in the effective small pores renal function [24]. The level of blood pressure before
radius. The increased small pore radius facilitates the the onset of diabetes is an important predictor of albu-
escape of albumin, but not IgG or IgM, into the urinary minuria in diabetic patients [25]. Proteinuria and glomer-
space. Thus, the impairment of charge selectivity of the ulosclerosis were reported to occur in patients with reno-
glomerular capillary wall is probably the major cause of vascular disease [26]. The increase in renal vascular
albuminuria in type 1 DN. resistance of patients with the metabolic syndrome of
Proximal tubular cell injury leads to an increase of insulin resistance, hypertension and high blood glucose
urinary content of the neutral IgG2 compared to the nega- may induce ischemia and structural changes in the glo-
tively charged IgG4 resulting in an increased IgG2/IgG4 meruli [27].
ratio [19]. Thus, an impairment of the tubular reabsorp- Until now, few studies have compared type 1 and type
tion may have contributed to the increased IgG2/IgG4 2 DN [28]. Indeed, the urinary IgM excretion, as a marker
ratio in type 2 DN compared to healthy controls. How- of a size selective injury in type 2 DN, to our knowledge
ever, the finding of an increased IgG2/IgG4 ratio in type 2 has not been studied before at all.
DN patients compared to the patients with nephrosclero- In conclusion, proteinuria in patients with type 1 DN
sis cannot be attributed to a tubular disease, since the is mainly due to impaired charge-selective properties of
degree of interstitial fibrosis as well as the renal function the glomerular capillary wall, while proteinuria in type 2
impairment was similar in both groups. Urine excretion DN is predominantly caused by a decreased size selectiv-
of 1-microglobulin correlated to the degree of intersti- ity of the glomerular capillary wall. This difference in the
tial fibrosis, which predicts the degree of kidney function patterns of proteinuria in type 1 and type 2 DN obtained
impairment [20, 21]. In our study, patients with type 1 DN in our study, in addition to the clinical and functional
and type 2 DN had a similar degree of tubulointerstitial differences, suggests different pathophysiological mech-
damage; they showed the same degree of renal function anisms of nephropathy in the two entities of diabetic
impairment and protein 1-microglobulin urine excre- renal disease.
tion. Again, the lack of association between increased
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